[HTML][HTML] Consensus on the treatment of dysphagia in Parkinson's disease
A Schindler, N Pizzorni, E Cereda, G Cosentino… - Journal of the …, 2021 - Elsevier
Background Dysphagia is common in Parkinson's disease (PD). The effects of
antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia …
antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia …
[HTML][HTML] Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
K Wang, ZH Liu, XY Li, YF Li, JR Li, JJ Hui… - Frontiers in Aging …, 2023 - frontiersin.org
Background: Drug efficacy generally varies with different durations. There is no systematic
review analyzing the effect of selegiline for Parkinson's disease (PD) on different treatment …
review analyzing the effect of selegiline for Parkinson's disease (PD) on different treatment …
Physical therapist management of Parkinson disease: a clinical practice guideline from the American Physical Therapy Association
JA Osborne, R Botkin, C Colon-Semenza… - Physical …, 2022 - academic.oup.com
A clinical practice guideline on Parkinson disease was developed by an American Physical
Therapy Association volunteer guideline development group that consisted of physical …
Therapy Association volunteer guideline development group that consisted of physical …
[HTML][HTML] Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer's disease and Parkinson's disease
X Fang, X Zhou, Y Miao, Y Han, J Wei, T Chen - Amb Express, 2020 - Springer
Alzheimer's disease (AD) and Parkinson's disease (PD) are neurodegenerative diseases
(NDD) characterized by progressive degeneration of the central nervous system, and few …
(NDD) characterized by progressive degeneration of the central nervous system, and few …
[HTML][HTML] Neuroprotective effect of ceftriaxone on MPTP-induced Parkinson's disease mouse model by regulating inflammation and intestinal microbiota
X Zhou, J Lu, K Wei, J Wei, P Tian, M Yue… - … Medicine and Cellular …, 2021 - hindawi.com
Parkinson's disease (PD) is a common degenerative disease of the central nervous system.
Although some drugs can alleviate the progress of PD, their long-term use will lead to …
Although some drugs can alleviate the progress of PD, their long-term use will lead to …
Effectiveness of interventions for dysphagia in Parkinson disease: a systematic review
Purpose: Dysphagia is a common sequela of Parkinson disease (PD) and is associated with
malnutrition, aspiration pneumonia, and mortality. This review article synthesized evidence …
malnutrition, aspiration pneumonia, and mortality. This review article synthesized evidence …
[HTML][HTML] Unleashing the potential of dance: A neuroplasticity-based approach bridging from older adults to Parkinson's disease patients
CJW Meulenberg, K Rehfeld, S Jovanović… - Frontiers in aging …, 2023 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder that affects> 1% of individuals
worldwide and is manifested by motor symptoms such as tremor, rigidity, and bradykinesia …
worldwide and is manifested by motor symptoms such as tremor, rigidity, and bradykinesia …
Frameworks for Parkinson's disease rehabilitation addressing when, what, and how
MR Rafferty, E Nettnin, JG Goldman… - Current neurology and …, 2021 - Springer
Abstract Purpose of Review This review summarizes the evidence on rehabilitation for
people with Parkinson's disease, including when to refer, what rehabilitation professionals …
people with Parkinson's disease, including when to refer, what rehabilitation professionals …
Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF‐KB pathway
J Lv, J Zhu, P Wang, T Liu, J Yuan, H Yin… - CNS Neuroscience …, 2023 - Wiley Online Library
Aims We performed cell and animal experiments to explore the therapeutic effect of
artemisinin on Parkinson's disease (PD) and the TLR4/Myd88 signaling pathway. Methods …
artemisinin on Parkinson's disease (PD) and the TLR4/Myd88 signaling pathway. Methods …
[HTML][HTML] Moving towards integrated and personalized care in Parkinson's disease: A framework proposal for training Parkinson nurses
M van Munster, J Stümpel, F Thieken… - Journal of personalized …, 2021 - mdpi.com
Delivering healthcare to people living with Parkinson's disease (PD) may be challenging in
face of differentiated care needs during a PD journey and a growing complexity. In this …
face of differentiated care needs during a PD journey and a growing complexity. In this …